abrdn Life Sciences Investors
2022 Q4 - 2025 Q4 (13 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/15/2026 | 3,867 | 0.0% | 230,437 | 12/31/2025 |
| 2025 Q3 | 10/20/2025 | 3,653 | 0.0% | 235,499 | 9/30/2025 |
| 2025 Q2 | 7/25/2025 | 3,017 | 0.0% | 235,499 | 6/30/2025 |
| 2025 Q1 | 4/24/2025 | 2,455 | 0.0% | 193,484 | 3/31/2025 |
| 2024 Q4 | 1/29/2025 | 2,179 | 0.0% | 166,051 | 12/31/2024 |
| 2024 Q3 | 10/18/2024 | 4,227 | 0.0% | 280,302 | 9/30/2024 |
| 2024 Q2 | 7/26/2024 | 4,912 | 0.0% | 346,621 | 6/30/2024 |
| 2024 Q1 | 4/29/2024 | 5,879 | 0.0% | 431,320 | 3/31/2024 |
| 2023 Q4 | 1/25/2024 | 6,113 | 0.0% | 454,154 | 12/31/2023 |
| 2023 Q3 | 10/27/2023 | 4,335 | 0.0% | 347,615 | 9/30/2023 |
| 2023 Q2 | 7/18/2023 | 4,192 | 0.0% | 309,615 | 6/30/2023 |
| 2023 Q1 | 4/13/2023 | 3,045 | 0.0% | 218,605 | 3/31/2023 |
| 2022 Q4 | 1/23/2023 | 2,215 | 0.0% | 155,884 | 12/31/2022 |